Tsai, C.-J.; Lin, Y.-C.; Chen, C.-Y.; Hung, C.-H.; Lin, Y.-C.
The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study. Biomedicines 2023, 11, 2510.
https://doi.org/10.3390/biomedicines11092510
AMA Style
Tsai C-J, Lin Y-C, Chen C-Y, Hung C-H, Lin Y-C.
The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study. Biomedicines. 2023; 11(9):2510.
https://doi.org/10.3390/biomedicines11092510
Chicago/Turabian Style
Tsai, Chia-Jung, Yu-Chih Lin, Chung-Yu Chen, Chih-Hsing Hung, and Yi-Ching Lin.
2023. "The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study" Biomedicines 11, no. 9: 2510.
https://doi.org/10.3390/biomedicines11092510
APA Style
Tsai, C. -J., Lin, Y. -C., Chen, C. -Y., Hung, C. -H., & Lin, Y. -C.
(2023). The Effects of Biologics on Hematologic Malignancy Development in Patients with Ankylosing Spondylitis, Psoriasis, or Psoriatic Arthritis: A National Cohort Study. Biomedicines, 11(9), 2510.
https://doi.org/10.3390/biomedicines11092510